compound_id,primary_drug,all_drug_names,smiles,smiles_source,mapping_status,mol_molecular_weight,mol_logp,mol_num_hbd,mol_num_hba,mol_num_rotatable_bonds,mol_tpsa,mol_num_aromatic_rings,mol_num_heavy_atoms,mol_formal_charge,mol_num_rings,mol_num_heteroatoms,mol_fraction_csp3,max_clinical_phase,clinical_status,primary_condition,nct_id,trial_title,data_source,compound_type,study_type,primary_phase,overall_status,lead_sponsor,sponsor_class,collected_date,efficacy_score,safety_score,success_probability
CLINICAL_TRIAL_00024,dapivirine (TMC120) vaginal gel,['dapivirine (TMC120) vaginal gel'],Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1,CHEMBL70663,success,329.41,4.76,2.0,5.0,,,,,0,,,,1.0,COMPLETED,,NCT00303576,A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel,clinical_trial_chembl_exact,Small molecule,CLINICAL_TRIAL,PHASE1,COMPLETED,"International Partnership for Microbicides, Inc.",CLINICAL_TRIAL,2025-09-01T15:43:11.075068,,,
CLINICAL_TRIAL_00019,Tirofiban (Aggrastat),['Tirofiban (Aggrastat)'],CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,CHEMBL916,success,440.61,2.95,3.0,5.0,,,,,0,,,,3.0,WITHDRAWN,,NCT01245725,Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention,clinical_trial_chembl_exact,Small molecule,CLINICAL_TRIAL,PHASE3,WITHDRAWN,Medicure,CLINICAL_TRIAL,2025-09-01T15:43:11.074868,,,
CLINICAL_TRIAL_00027,Telotristat Ethyl,['Telotristat Ethyl'],CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1,CHEMBL2105695,success,574.99,4.99,2.0,9.0,,,,,0,,,,2.0,WITHDRAWN,,NCT04776876,Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome,clinical_trial_chembl_exact,Small molecule,CLINICAL_TRIAL,PHASE2,WITHDRAWN,M.D. Anderson Cancer Center,CLINICAL_TRIAL,2025-09-01T15:43:11.075161,,,
CLINICAL_TRIAL_00021,Gabapentin immediate release,['Gabapentin immediate release'],CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C,CHEMBL1628502,success,329.39,2.68,2.0,5.0,,,,,0,,,,4.0,TERMINATED,,NCT02117076,"Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome",clinical_trial_chembl_exact,Small molecule,CLINICAL_TRIAL,PHASE4,TERMINATED,"Theresa Zesiewicz, MD",CLINICAL_TRIAL,2025-09-01T15:43:11.074974,,,
